Success Metrics

Active Trials
1(20%)

Phase Distribution

Ph phase_4
1
20%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution1 total trials
Phase 4Post-market surveillance
1(100.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Other(3)

Detailed Status

unknown3
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 41 (100.0%)

Trials by Status

not_yet_recruiting120%
recruiting120%
unknown360%

Recent Activity

1 active trials
Showing 5 of 5
recruitingphase_4

Prevention of Postoperative Endoscopic Recurrence With Endoscopy-driven Versus Systematic Biological Therapy

NCT05169593
not_yet_recruiting

Articular Damage in Patients With Juvenile Idiopathic Arthritis After Transition to Adult Care

NCT06895278
unknown

Fluctuation Analyses of Asthma Patients With Biologics Use

NCT06024707
unknown

Outcomes of Biological Therapy on Rheumatoid Arthritis

NCT05267431
unknown

Hematological Indices and Fecal Calprotectin Predict Histological Remission in Ulcerative Colitis

NCT04818788

Clinical Trials (5)

Showing 5 of 5 trials
NCT05169593Phase 4

Prevention of Postoperative Endoscopic Recurrence With Endoscopy-driven Versus Systematic Biological Therapy

Recruiting
NCT06895278

Articular Damage in Patients With Juvenile Idiopathic Arthritis After Transition to Adult Care

Not Yet Recruiting
NCT06024707

Fluctuation Analyses of Asthma Patients With Biologics Use

Unknown
NCT05267431

Outcomes of Biological Therapy on Rheumatoid Arthritis

Unknown
NCT04818788

Hematological Indices and Fecal Calprotectin Predict Histological Remission in Ulcerative Colitis

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5